Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Exploratory bioinformatics study of lncRNAs in Alzheimer's disease mRNA sequences with application to drug development.

Holden T, Nguyen A, Lin E, Cheung E, Dehipawala S, Ye J, Tremberger G Jr, Lieberman D, Cheung T.

Comput Math Methods Med. 2013;2013:579136. doi: 10.1155/2013/579136. Epub 2013 Apr 11.

2.

Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.

Jiao B, Tang B, Liu X, Xu J, Wang Y, Zhou L, Zhang F, Yan X, Zhou Y, Shen L.

Neurobiol Aging. 2014 Aug;35(8):1957.e1-6. doi: 10.1016/j.neurobiolaging.2014.02.014. Epub 2014 Feb 20.

PMID:
24650794
3.

Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.

Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, Al-Sarraj S, Niblock M, Gallo JM, Adnan J, Killick R, Brown KS, Medway C, Lord J, Turton J, Bras J; Alzheimer's Research UK Consortium, Morgan K, Powell JF, Singleton A, Hardy J.

Neurobiol Aging. 2014 Dec;35(12):2881.e1-6. doi: 10.1016/j.neurobiolaging.2014.06.002. Epub 2014 Jun 16.

4.

[Alzheimer's disease. Present and future role of genetics].

Roks G.

Tijdschr Gerontol Geriatr. 2003 Feb;34(1):13-20. Dutch.

PMID:
12629906
5.

Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.

Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, Gandy S.

Acta Neuropathol Commun. 2016 Feb 25;4:16. doi: 10.1186/s40478-016-0282-y.

6.

Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J.

Neurology. 2003 Jan 28;60(2):235-9.

PMID:
12552037
7.

Genetics of Alzheimer's disease.

Alonso Vilatela ME, López-López M, Yescas-Gómez P.

Arch Med Res. 2012 Nov;43(8):622-31. doi: 10.1016/j.arcmed.2012.10.017. Epub 2012 Nov 8. Review.

PMID:
23142261
8.

Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.

Lee DY, Moon J, Lee ST, Jung KH, Park DK, Yoo JS, Sunwoo JS, Byun JI, Shin JW, Jeon D, Jung KY, Kim M, Lee SK, Chu K.

J Alzheimers Dis. 2015;45(3):837-49. doi: 10.3233/JAD-142919.

PMID:
25624420
9.

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.

An SS, Park SA, Bagyinszky E, Bae SO, Kim YJ, Im JY, Park KW, Park KH, Kim EJ, Jeong JH, Kim JH, Han HJ, Choi SH, Kim S.

Clin Interv Aging. 2016 Dec 15;11:1817-1822. doi: 10.2147/CIA.S116724. eCollection 2016.

10.

Genetic study of Sardinian patients with Alzheimer's disease.

Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A.

Neurosci Lett. 2006 May 1;398(1-2):124-8. Epub 2006 Jan 19.

PMID:
16423463
11.

[Alzheimer's disease and genetics].

Rongve A, Årsland D, Graff C.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1449-52. doi: 10.4045/tidsskr.12.0873. Review. Norwegian.

12.

Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1‑AS expression.

Liu T, Huang Y, Chen J, Chi H, Yu Z, Wang J, Chen C.

Mol Med Rep. 2014 Sep;10(3):1275-81. doi: 10.3892/mmr.2014.2351. Epub 2014 Jun 23.

13.

Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity.

Nornes S, Newman M, Verdile G, Wells S, Stoick-Cooper CL, Tucker B, Frederich-Sleptsova I, Martins R, Lardelli M.

Hum Mol Genet. 2008 Feb 1;17(3):402-12. Epub 2007 Nov 2.

PMID:
17981814
14.

Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer's disease.

Park HK, Na DL, Lee JH, Kim JW, Ki CS.

J Korean Med Sci. 2008 Apr;23(2):213-7. doi: 10.3346/jkms.2008.23.2.213.

15.

Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.

Johnston JA, Norgren S, Ravid R, Wasco W, Winblad B, Lannfelt L, Cowburn RF.

Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):85-95.

PMID:
9037522
16.

The genetics of Alzheimer's disease.

Bertram L, Tanzi RE.

Prog Mol Biol Transl Sci. 2012;107:79-100. doi: 10.1016/B978-0-12-385883-2.00008-4. Review.

PMID:
22482448
17.

Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.

Soler-López M, Zanzoni A, Lluís R, Stelzl U, Aloy P.

Genome Res. 2011 Mar;21(3):364-76. doi: 10.1101/gr.114280.110. Epub 2010 Dec 16.

18.

Molecular genetics of Alzheimer's disease.

Cruts M, Van Broeckhoven C.

Ann Med. 1998 Dec;30(6):560-5. Review.

PMID:
9920359
19.

Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.

Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St Jean P, Lawson M, Ehm MG, Mayeux R, Goate AM; NIA-LOAD/NCRAD Family Study Consortium.

PLoS One. 2012;7(2):e31039. doi: 10.1371/journal.pone.0031039. Epub 2012 Feb 1. Erratum in: PLoS One. 2012;7(5): doi/10.1371/annotation/c92e16da-7733-421d-b063-1db19488daa6. Haller, Gabe [added]..

Supplemental Content

Support Center